Zhejiang Yatai Pharmaceutical Co., Ltd.

002370.SZ

002370.SZZhejiang Yatai Pharmaceutical Co., Ltd. CN flag

Shenzhen

3.98

CNY

+0.04

(+1.02%)

-0.03EPS

-132.67P/E

2.49BMarket Cap

Apr 18Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

Zhejiang Yatai Pharmaceutical Co., Ltd.

002370.SZ

(Shenzhen)

Recent

price

3.98

P/E

ratio

-132.67

div

yld

- -

ROIC.AI

Legends:

Stock price

Beta (1.0 Market)

% total return 12/11

Stock

S&P500

-12.53

30.48

-3.16

29.20

-41.30

91.72

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	TTM
1.35	1.42	1.14	1.01	0.8	0.86	0.93	1.13	1.73	1.69	2.1	1.32	0.94	0.59	0.7	0.71	0.7	Revenue per Share
0.14	0.16	0.11	0.11	-0.06	0.01	0.1	0.14	0.22	0.26	0.28	-3.58	0.05	-0.43	-0.25	-0.02	-0.03	Basic EPS, GAAP
-0.08	0.19	-0.19	0.03	-0.1	0.02	-0.05	0.16	-0.26	-0.29	-1.1	-0.65	-0.04	-0.04	-0.02	0.01	-0.02	Free Cash Flow per Basic Share
0.03	0.08	0.01	0.05	0.05	- -	0.01	0.06	0.1	0.05	0.11	0.08	0.03	0.03	0.03	0.03	0.02	Dividend per Share
0.56	0.65	0.7	0.89	0.83	0.91	0.9	0.96	1.22	1.69	1.85	-1.75	-1.67	-2.15	-2.4	-2.04	-1.96	Book Value per Share
0.57	0.68	1.82	1.73	1.68	1.84	1.7	0.08	3.2	2.84	2.79	0.99	1	0.59	0.42	0.86	0.91	Tangible Book Value per Share
308	303	382	417	396	365	406	411	440	537	539	537	545	531	531	594	612	Basic Weighted Avg Shares
415	430	435	420	316	314	376	463	762	907	1,132	709	515	315	373	421	426	Sales/Revenue/Turnover
13.35	15.09	11.47	10.13	-9.62	1.46	12.4	13.57	17.82	17.99	17.5	-17	-11.38	-39.02	-2.45	-6.19	-1.6	Operating Margin (%)
13	14	17	19	20	24	25	29	39	38	44	53	49	44	42	39	- -	Depreciation Expense
42	48	42	44	-26	5	41	55	97	140	151	-1,921	27	-228	-133	-12	-17	Net Income, GAAP
14.4	15.57	12.93	13.18	- -	5.51	16.16	14.39	10.5	14.11	12.62	- -	3.95	- -	- -	- -	- -	Effective Tax Rate (%)
10.02	11.21	9.66	10.42	-8.14	1.75	10.8	11.98	12.7	15.38	13.33	-270.79	5.3	-72.44	-35.53	-2.82	-3.9	Profit Margin (%)
43	37	465	468	390	400	394	99	947	907	810	1,309	982	782	782	793	218	Working Capital
24	- -	- -	- -	- -	- -	- -	513	- -	100	165	982	933	863	900	639	- -	LT Debt
199	230	720	745	704	710	747	793	2,166	2,278	2,376	633	660	433	301	581	625	Total Equity
14.95	15.73	7.63	4.67	- -	0.59	5.26	4.63	6.5	6.14	6.91	- -	-3.34	- -	- -	- -	- -	Return on Invested Capital (%)
17.2	17.06	13.85	12.15	- -	1.74	11.13	7.55	13.68	17.45	13.95	- -	86.7	- -	- -	- -	- -	Return on Capital (%)
27.05	25.99	18.14	13.75	-7.35	1.65	11.6	14.58	20.81	19.33	15.85	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	7.91%	-14.49%	12.64%
Net Income, GAAP	-173.99%	-508.74%	-91.05%
Free Cash Flow	-110.21%	-75.18%	-179.42%
Total Cash Common Dividend	99.63%	-16.42%	18.83%
Total Equity	15.29%	-8.22%	92.81%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Similar Companies: ZIM Laboratories Limited (ZIMLAB.BO)
Kissei Pharmaceutical Co., Ltd. (KSPHF)
Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
Modalis Therapeutics Corporation (4883.T)
Stenocare A/S (STENO.CO)
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
Business: Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. It offers tablets, capsules, patches, powder injections, and troches. It also provides chemical agents and raw materials, and diagnostic reagents, as well as pharmaceutical research and development outsourcing services. Zhejiang Yatai Pharmaceutical Co., Ltd. was founded in 1989 and is based in Shaoxing, China.

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	TTM
1.35	1.42	1.14	1.01	0.8	0.86	0.93	1.13	1.73	1.69	2.1	1.32	0.94	0.59	0.7	0.71	0.7	Revenue per Share
0.14	0.16	0.11	0.11	-0.06	0.01	0.1	0.14	0.22	0.26	0.28	-3.58	0.05	-0.43	-0.25	-0.02	-0.03	Basic EPS, GAAP
-0.08	0.19	-0.19	0.03	-0.1	0.02	-0.05	0.16	-0.26	-0.29	-1.1	-0.65	-0.04	-0.04	-0.02	0.01	-0.02	Free Cash Flow per Basic Share
0.03	0.08	0.01	0.05	0.05	- -	0.01	0.06	0.1	0.05	0.11	0.08	0.03	0.03	0.03	0.03	0.02	Dividend per Share
0.56	0.65	0.7	0.89	0.83	0.91	0.9	0.96	1.22	1.69	1.85	-1.75	-1.67	-2.15	-2.4	-2.04	-1.96	Book Value per Share
0.57	0.68	1.82	1.73	1.68	1.84	1.7	0.08	3.2	2.84	2.79	0.99	1	0.59	0.42	0.86	0.91	Tangible Book Value per Share
308	303	382	417	396	365	406	411	440	537	539	537	545	531	531	594	612	Basic Weighted Avg Shares
415	430	435	420	316	314	376	463	762	907	1,132	709	515	315	373	421	426	Sales/Revenue/Turnover
13.35	15.09	11.47	10.13	-9.62	1.46	12.4	13.57	17.82	17.99	17.5	-17	-11.38	-39.02	-2.45	-6.19	-1.6	Operating Margin (%)
13	14	17	19	20	24	25	29	39	38	44	53	49	44	42	39	- -	Depreciation Expense
42	48	42	44	-26	5	41	55	97	140	151	-1,921	27	-228	-133	-12	-17	Net Income, GAAP
14.4	15.57	12.93	13.18	- -	5.51	16.16	14.39	10.5	14.11	12.62	- -	3.95	- -	- -	- -	- -	Effective Tax Rate (%)
10.02	11.21	9.66	10.42	-8.14	1.75	10.8	11.98	12.7	15.38	13.33	-270.79	5.3	-72.44	-35.53	-2.82	-3.9	Profit Margin (%)
43	37	465	468	390	400	394	99	947	907	810	1,309	982	782	782	793	218	Working Capital
24	- -	- -	- -	- -	- -	- -	513	- -	100	165	982	933	863	900	639	- -	LT Debt
199	230	720	745	704	710	747	793	2,166	2,278	2,376	633	660	433	301	581	625	Total Equity
14.95	15.73	7.63	4.67	- -	0.59	5.26	4.63	6.5	6.14	6.91	- -	-3.34	- -	- -	- -	- -	Return on Invested Capital (%)
17.2	17.06	13.85	12.15	- -	1.74	11.13	7.55	13.68	17.45	13.95	- -	86.7	- -	- -	- -	- -	Return on Capital (%)
27.05	25.99	18.14	13.75	-7.35	1.65	11.6	14.58	20.81	19.33	15.85	- -	- -	- -	- -	- -	- -	Return on Common Equity (%)

	Mar'24	Jun'24	Sep'24
Total Current Assets	897	912	905
Accounts Receivable, Net	72	75	80
Cash, Cash Equivalents & STI	663	686	689
Inventories	92	82	69
Total Current Liabilities	101	736	686
Payables & Accruals	- -	- -	- -
ST Debt	- -	646	607
Deferred Revenue	- -	- -	- -

	Mar'24	Jun'24	Sep'24
ST Debt	- -	646	607
LT Borrowings	637	- -	- -
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	609	609	625
Market Capitalization	2,166	1,524	2,007

Zhejiang Yatai Pharmaceutical Co., Ltd.

Growth Rates

(avg. rate of change)

Working Capital

Capital Structure

Growth Rates

(avg. rate of change)

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year

Year	Q1	Q2	Q3	Q4	FY
2022	68	93	73	139	373
2023	124	98	81	119	421
2024	113	109	85	- -	- -